NO991734L - Pyrazolinones for the treatment of potency disorders - Google Patents
Pyrazolinones for the treatment of potency disordersInfo
- Publication number
- NO991734L NO991734L NO991734A NO991734A NO991734L NO 991734 L NO991734 L NO 991734L NO 991734 A NO991734 A NO 991734A NO 991734 A NO991734 A NO 991734A NO 991734 L NO991734 L NO 991734L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- pyrazolinones
- potency disorders
- disorders
- potency
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Anvendelse av forbindelser med formel (I) hvor R1, R2 og R3 har de i krav l angitte betydninger, til behandling og/eller terapi av potensforstyrrel- ser.Use of compounds of formula (I) wherein R 1, R 2 and R 3 have the meanings specified in claim 1 for the treatment and / or therapy of power disorders.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19642284A DE19642284A1 (en) | 1996-10-14 | 1996-10-14 | Pyrazolinones for the treatment of erectile dysfunction |
PCT/EP1997/005532 WO1998016224A1 (en) | 1996-10-14 | 1997-10-08 | Pyrazolinones to treat disturbances of potency |
Publications (2)
Publication Number | Publication Date |
---|---|
NO991734L true NO991734L (en) | 1999-04-13 |
NO991734D0 NO991734D0 (en) | 1999-04-13 |
Family
ID=7808669
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO991734A NO991734D0 (en) | 1996-10-14 | 1999-04-13 | Pyrazolinones for the treatment of potency disorders |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0930881A1 (en) |
JP (1) | JP2001501958A (en) |
KR (1) | KR20000049086A (en) |
CN (1) | CN1233178A (en) |
AR (1) | AR008494A1 (en) |
AU (1) | AU4945297A (en) |
BR (1) | BR9712307A (en) |
CA (1) | CA2268823A1 (en) |
DE (1) | DE19642284A1 (en) |
HU (1) | HUP0000233A3 (en) |
NO (1) | NO991734D0 (en) |
PL (1) | PL332821A1 (en) |
WO (1) | WO1998016224A1 (en) |
ZA (1) | ZA979151B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6410584B1 (en) | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
US6875575B1 (en) | 1998-11-25 | 2005-04-05 | Osi Pharmaceuticals, Inc. | Diagnostic methods for neoplasia |
US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9311920D0 (en) * | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
DE19518082A1 (en) * | 1995-05-17 | 1996-11-21 | Merck Patent Gmbh | 4 (-Arylaminomethylene) -2,4-dihydropyrazol-3-one |
-
1996
- 1996-10-14 DE DE19642284A patent/DE19642284A1/en not_active Withdrawn
-
1997
- 1997-10-08 AU AU49452/97A patent/AU4945297A/en not_active Abandoned
- 1997-10-08 JP JP10517987A patent/JP2001501958A/en active Pending
- 1997-10-08 EP EP97912141A patent/EP0930881A1/en not_active Withdrawn
- 1997-10-08 KR KR1019990703161A patent/KR20000049086A/en not_active Application Discontinuation
- 1997-10-08 PL PL97332821A patent/PL332821A1/en unknown
- 1997-10-08 BR BR9712307-2A patent/BR9712307A/en not_active Application Discontinuation
- 1997-10-08 CN CN97198764A patent/CN1233178A/en active Pending
- 1997-10-08 CA CA002268823A patent/CA2268823A1/en not_active Abandoned
- 1997-10-08 HU HU0000233A patent/HUP0000233A3/en unknown
- 1997-10-08 WO PCT/EP1997/005532 patent/WO1998016224A1/en not_active Application Discontinuation
- 1997-10-13 ZA ZA9709151A patent/ZA979151B/en unknown
- 1997-10-14 AR ARP970104715A patent/AR008494A1/en unknown
-
1999
- 1999-04-13 NO NO991734A patent/NO991734D0/en unknown
Also Published As
Publication number | Publication date |
---|---|
DE19642284A1 (en) | 1998-04-16 |
WO1998016224A1 (en) | 1998-04-23 |
AR008494A1 (en) | 2000-01-19 |
PL332821A1 (en) | 1999-10-11 |
HUP0000233A2 (en) | 2001-04-28 |
BR9712307A (en) | 1999-08-31 |
EP0930881A1 (en) | 1999-07-28 |
ZA979151B (en) | 1998-05-11 |
JP2001501958A (en) | 2001-02-13 |
CN1233178A (en) | 1999-10-27 |
KR20000049086A (en) | 2000-07-25 |
HUP0000233A3 (en) | 2001-06-28 |
CA2268823A1 (en) | 1998-04-23 |
NO991734D0 (en) | 1999-04-13 |
AU4945297A (en) | 1998-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO992821L (en) | Ketobenzamides as Calpain Inhibitors | |
TR199901172T2 (en) | Newly substituted pyrazole derivatives. | |
NO20075065L (en) | Use of isoflavone compounds to treat heart disease | |
TR199901905T2 (en) | 2- (P�rin-9-yl) -tetrahidrofuran-3,4-diol t�revleri. | |
BG105270A (en) | Tetrahydropyridoethers | |
MX9700557A (en) | Dihydrobenzofuranes. | |
NO991951L (en) | Tienopyrimidines with phosphodiesterase V inhibitory effect | |
EA200000723A1 (en) | DERIVATIVES 2- (PURIN-9-IL) -TETRAHYDROFURAN-3,4-DIOLA | |
IL119462A (en) | 1-trimethylphenyl-3-substituted 1H-pyrrol-2-amines | |
TR200000059T2 (en) | Pyridine derivatives | |
GB9514473D0 (en) | Chemical compounds | |
AU2291097A (en) | Novel phenanthridines substituted in the 6 position | |
BG103399A (en) | New heterocycle-substituted benzamides and their application for the treatment of diseases | |
DE69723863D1 (en) | CHINOLINE AND THEIR THERAPEUTIC USE | |
ZA984463B (en) | Fused dihydropyrans | |
IT1285770B1 (en) | CORTICOID COMPOUNDS | |
NO994584L (en) | Tetrahydropyridforbindelser | |
NO991734L (en) | Pyrazolinones for the treatment of potency disorders | |
NZ240481A (en) | Aminosulphonyl urea derivatives and pharmaceutical compositions | |
NO20001934L (en) | 3-Substituted tetrahydropyridopyrimidinone derivatives, their preparation and use | |
EP0235064A3 (en) | Aromatic compounds with amide structure, derivatives of amino-benzoic acids, hydroxybenzoic acids, cinnamic acids, urocanic acids and benzimidazoles, absorbing uvb and/or uva | |
TR199901386T2 (en) | �midazopiridazinler. | |
TR200200278T2 (en) | Calcilitic compositions | |
ATE39694T1 (en) | (PYRROL-1-YL)-PHENYL-DIHYDROPYRIDAZINONES, THEIR PREPARATION AND USE. | |
MX9700624A (en) | Imidazopyridine-azolidinones. |